Addressing the Osteoporosis Problem—Multifunctional Injectable Hybrid Materials for Controlling Local Bone Tissue Remodeling
Source abstract
Abstract
Novel multifunctional biomimetic injectable hybrid systems were synthesized. The physicochemical as well as biological in vitro and in vivo tests demonstrated that they are promising candidates for bone tissue regeneration. The hybrids are composed of a biopolymeric collagen/chitosan/hyaluronic acid matrix and amine group-functionalized silica particles decorated with apatite to which the alendronate molecules were coordinated. The components of these systems were integrated and stabilized by cross-linking with genipin, a compound of natural origin. They can be precisely injected into the diseased tissue in the form of a viscous sol or a partially cross-linked hydrogel, where they can serve as scaffolds for locally controlled bone tissue regeneration/remodeling by supporting the osteoblast formation/proliferation and maintaining the optimal osteoclast level. These materials lack systemic toxicity. They can be particularly useful for the repair of small osteoporotic bone defects.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gene expression and cancer classification
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Kraków, Poland
Faculty of Physics and Applied Computer Science, AGH University of Science and Technology, Mickiewicza 30, 30-059 Kraków, Poland
Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland
Department of Pathomorphology, Jagiellonian University Medical College, 30-387 Kraków, Poland
Funding
Narodowe Centrum Nauki · Innovation of the Jagiellonian University of CTT CITTRU funds · EU Project POWR
References (64)
Show source-provided references
1. 10.3390/pharmaceutics1201008310.3390/pharmaceutics12010083 ↗
2. 10.1126/science.289.5484.150410.1126/science.289.5484.1504 ↗
3. 10.1007/s00198-004-1787-y10.1007/s00198-004-1787-y ↗
4. 10.1080/0300820029000093410.1080/03008200290000934 ↗
5. 10.1039/d0bm00376j10.1039/d0bm00376j ↗
6. 10.3934/bioeng.2017.2.25910.3934/bioeng.2017.2.259 ↗
7. 10.1016/j.bone.2007.03.00210.1016/j.bone.2007.03.002 ↗
8. 10.1080/1061186x.2017.139067010.1080/1061186x.2017.1390670 ↗
9. 10.1021/am501048n10.1021/am501048n ↗
10. 10.1016/j.msec.2019.10989710.1016/j.msec.2019.109897 ↗
11. 10.1016/j.colsurfb.2016.03.02510.1016/j.colsurfb.2016.03.025 ↗
12. 10.1016/j.msec.2019.10999410.1016/j.msec.2019.109994 ↗
13. 10.1016/j.nano.2011.11.00310.1016/j.nano.2011.11.003 ↗
14. 10.1177/204173141876828510.1177/2041731418768285 ↗
15. 10.1016/j.ijbiomac.2019.06.18410.1016/j.ijbiomac.2019.06.184 ↗
16. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
17. 10.1016/s0731-7085(02)00021-310.1016/s0731-7085(02)00021-3 ↗
18. 10.1016/j.ijbiomac.2018.02.16110.1016/j.ijbiomac.2018.02.161 ↗
19. 10.1016/j.colsurfb.2018.06.00410.1016/j.colsurfb.2018.06.004 ↗
20. 10.1016/B978-0-12-411619-1.00004-510.1016/B978-0-12-411619-1.00004-5 ↗
21. 10.1111/j.1151-2916.2002.tb00383.x10.1111/j.1151-2916.2002.tb00383.x ↗
22. 10.1002/(sici)1097-4636(19970305)34:3<305::aid-jbm5>3.0.co;2-o10.1002/(sici)1097-4636(19970305)34:3<305::aid-jbm5>3.0.co;2-o ↗
23. 10.1590/s1517-707620180004.055110.1590/s1517-707620180004.0551 ↗
24. Ananchenko, G.; Novakovic, J.; Tikhomirova, A. Profiles of Drug Substances, Excipients, and Related Methodology; Elsevier Inc., 2013; Vol. 38, pp 1–33.10.1016/B978-0-12-407691-4.00001-0 ↗
25. 10.1002/app.3340410.1002/app.33404 ↗
26. 10.1016/s0169-4332(01)00491-310.1016/s0169-4332(01)00491-3 ↗
27. 10.1016/j.matdes.2018.03.01010.1016/j.matdes.2018.03.010 ↗
28. 10.1016/j.msec.2016.03.06010.1016/j.msec.2016.03.060 ↗
29. 10.1016/j.biomaterials.2017.01.01610.1016/j.biomaterials.2017.01.016 ↗
30. 10.1021/acsami.6b1049110.1021/acsami.6b10491 ↗
31. 10.1016/j.ijbiomac.2019.11.05210.1016/j.ijbiomac.2019.11.052 ↗
32. 10.1016/j.actbio.2015.03.01810.1016/j.actbio.2015.03.018 ↗
33. 10.1016/j.molliq.2019.01.08910.1016/j.molliq.2019.01.089 ↗
34. 10.1016/j.msec.2019.10998510.1016/j.msec.2019.109985 ↗
35. 10.1002/jbm.a.3481010.1002/jbm.a.34810 ↗
36. 10.1016/j.colsurfb.2007.06.01910.1016/j.colsurfb.2007.06.019 ↗
37. 10.1007/s12541-013-0298-110.1007/s12541-013-0298-1 ↗
38. 10.1016/j.msec.2011.09.01210.1016/j.msec.2011.09.012 ↗
39. 10.1179/1743280414y.000000003810.1179/1743280414y.0000000038 ↗
40. 10.1016/j.ijbiomac.2018.06.20010.1016/j.ijbiomac.2018.06.200 ↗
41. 10.1039/c4tb00327f10.1039/c4tb00327f ↗
42. 10.1016/j.ijpharm.2005.10.04410.1016/j.ijpharm.2005.10.044 ↗
43. 10.1016/j.ijpharm.2009.10.02110.1016/j.ijpharm.2009.10.021 ↗
44. 10.1016/0168-3659(87)90035-610.1016/0168-3659(87)90035-6 ↗
45. 10.1021/am100972r10.1021/am100972r ↗
46. 10.1088/1748-6041/10/1/01502010.1088/1748-6041/10/1/015020 ↗
47. 10.1016/j.colsurfb.2014.10.02610.1016/j.colsurfb.2014.10.026 ↗
48. 10.1016/j.carbpol.2015.03.03310.1016/j.carbpol.2015.03.033 ↗
49. 10.1016/j.actbio.2008.02.02510.1016/j.actbio.2008.02.025 ↗
50. 10.1016/j.biomaterials.2008.07.03810.1016/j.biomaterials.2008.07.038 ↗
51. 10.1016/j.cej.2020.12489510.1016/j.cej.2020.124895 ↗
52. 10.1039/c8ra03550d10.1039/c8ra03550d ↗
53. 10.1039/c7nr04785a10.1039/c7nr04785a ↗
54. 10.1016/j.ijbiomac.2010.03.01510.1016/j.ijbiomac.2010.03.015 ↗
55. 10.1016/j.bone.2010.08.00810.1016/j.bone.2010.08.008 ↗
56. 10.3390/ijms16112598210.3390/ijms161125982 ↗
57. 10.1002/(sici)1097-4652(199905)179:2<142::aid-jcp4>3.0.co;2-q10.1002/(sici)1097-4652(199905)179:2<142::aid-jcp4>3.0.co;2-q ↗
58. 10.1016/j.bbrc.2011.01.07110.1016/j.bbrc.2011.01.071 ↗
59. 10.1016/j.bcp.2006.09.03110.1016/j.bcp.2006.09.031 ↗
60. 10.1016/j.bioactmat.2020.06.01010.1016/j.bioactmat.2020.06.010 ↗
61. 10.1016/j.biomaterials.2016.02.03910.1016/j.biomaterials.2016.02.039 ↗
62. 10.1016/j.actbio.2009.01.00810.1016/j.actbio.2009.01.008 ↗
63. 10.1021/ja304907c10.1021/ja304907c ↗
64. 10.4238/gmr1601948510.4238/gmr16019485 ↗